Drug firm Strides Arcolab plans to raise up to Rs 1,500 crore through various market instruments.
“The board of directors of the company has approved the proposal to raise long-term funds by way of issue of GDRs/ADRs /FCCBs/QIP or such other equity linked instruments as may be permissible for an amount up to Rs 1,500 crore including a green shoe option,” Strides Arcolab said in a BSE filing.
It added: “The fund raising is subject to shareholders’ approval and such other statutory approvals as may be required including that of Foreign Investment Promotion Board.”
Shares of Strides Arcolab were trading at Rs 1,240.65 apiece, 0.18 per cent, on the BSE.